-
CycleTrack and SDN are teaming up to make medical school admissions more transparent and accessible! Read the announcement to learn how we’re supporting the future of CycleTrack’s free application-tracking tools .
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an alternative browser.
You should upgrade or use an alternative browser.
Diluting Omnipaque?
Started by GlowInTheDark
Get help with your application
Use all the free resources available to you from SDN: articles, guides, expert advising, forums discussions, and school research.
I've been diluting. All I can get is 300mg/mL and 350mg/mL. Dilute down to close to 240. For the 350mg/mL, that's 2cc contrast to 1cc saline, final concentration of 233 mg/mL.
Last edited:
Advertisement - Members don't see this ad
That’s what we were tossing around, 2:1. You think a 1:1 with 175 mg/mL would have good visualization?I've been diluting. All I can get is 300mg/mL and 350mg/mL. Dilute down to close to 240. For the 350mg/mL, that's 2cc contrast to 1cc saline, final concentration of 233 mg/mL.
We have been diluting for kyphoplasties without issue.
We are diluting isovue M to not waste the whole bottle.
I believe you can get pyrogen free 350 and 140. I’m trying to understand reason for IT contraindication but can’t find much clarification from labeling and FDA.I asked the same question to the Pharmacist consultant at my asc. See attached. Bottom line- don’t use 350 or 140 on esi, diluted or not. Similar level of concern as Gadolinium on my end.
ive been "diluting" down omnipaque for years.
draw up 2-3 cc, use oh say 0.5 cc in to the LOR syringe, add maybe 2 to 3 ml NS to taste, and inject away.
if i cant see the omnipaque in the LOR syringe on CLO, then attach the remaining 1-2 ml omnipaque.
draw up 2-3 cc, use oh say 0.5 cc in to the LOR syringe, add maybe 2 to 3 ml NS to taste, and inject away.
if i cant see the omnipaque in the LOR syringe on CLO, then attach the remaining 1-2 ml omnipaque.
We dilute down to Omnipaque 300 to somewhere around 180-200. Only time it causes a problem is on very obese patients - try to remember not to dilute those cases. Haven't seen any clinical outcome difference. Can still see vascular flow when it occurs.